Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease

Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease: Part 3 Pilot Trial

This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for inflammatory bowel disease. This research will increase the understanding of the role of a self-management program in improving health and health-related quality of life for patients with inflammatory bowel disease.

The study team hypothesizes:

• the study will achieve a recruitment rate of 10 participants every 3 months
• 70% participant retention at 24 weeks
• 70% outcome data collection
• 70% intervention completion
• high acceptability

Inclusion Criteria:

• Diagnosis of Inflammatory Bowel Disease (IBD) based on conventional clinical, endoscopic, and histopathological criteria, clinically active IBD
• Impaired health-related quality of life
• Clinically active IBD will be indicated by both a modified Harvey Bradshaw Index (HBI) ≥5 for Crohn's disease (CD) or a Simple Clinical Colitis Activity Index (SCCAI) ≥3 for ulcerative colitis (UC)
• Fecal calprotectin > 250 microgram (ug/g)
• Impaired IBD-specific health-related quality of life will be defined as a Short IBD Questionnaire score ≤ 60

Exclusion Criteria:

• Unable to speak and read English
• Unable to access the internet regularly by phone or web as this will impair participants ability to engage with the intervention components
• Have an ileostomy, colostomy, ileoanal pouch, or ileorectal anastomoses
• Are planned for imminent surgery
• Have short bowel syndrome
• Uncontrolled medical or psychiatric disease